DISPOSITION OF DRUGS The disposition of chemicals entering the body (from C.D. Klaassen, Casarett and Doull’s Toxicology, 5th ed., New York: McGraw-Hill,

Slides:



Advertisements
Similar presentations
PHARMACOKINETIC MODELS
Advertisements

Clinical Pharmacokinetics
PHARMACOKINETIC.
Module 2 # 2 Pharmacokinetics absorption of drugs drugs can be given iv, im, sc, orally (po) if given parenterally, they should.
Pharmacokinetics -- part 1 --
Nonlinear pharmacokinetics
Laplace transformation
Practical Pharmacokinetics
Practical Pharmacokinetics September 11, 2007 Frank F. Vincenzi.
Pharmacokinetics Based on the hypothesis that the action of a drug requires presence of a certain concentration in the fluid bathing the target tissue.
Dose Adjustment in Renal and Hepatic Disease
Pharmacokinetics: Asmah Nasser, M.D..
Toxicokinetic Calculations
INTRAVENOUS INFUSION.
Pharmacology Department
Drug Disposition Porofessor Hanan hager Dr.Abdul latif Mahesar College of medicine King Saud University.
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
VM 8314 Dr. Jeff Wilcke Pharmacokinetic Modeling (describing what happens)
CLEARANCE CONCEPTS Text: Applied Biopharm. & PK
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 4 Pharmacokinetics.
Quantitative Pharmacokinetics
The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida.
PHARMACOKINETICS 1. Fate of drugs in the body 1.1 absorption
Nonlinear Pharmacokinetics
Pharmacokinetics Introduction
Lecture 2.  Clearance Ability to eliminate the drug  Volume of distribution (Vd) The measure of the apparent space in the body available to contain.
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
Pharmacology Department
Chapter 4 Pharmacokinetics Copyright © 2011 Delmar, Cengage Learning.
PHARMACOKINETIC MODELS
PHARMACOKINETICS Part 3.
Drug Administration Pharmacokinetic Phase (Time course of ADME processes) Absorption Distribution Pharmaceutical Phase Disintegration of the Dosage Form.
One Compartment Open Model IV bolus
The General Concepts of Pharmacokinetics and Pharmacodynamics
1 Single-dose kinetics Plasma [Drug] curve Upon administration [drug] plasma reaches a max Then begins to decline as the Drug is eliminated Cp max = max.
1 TOXICOKINETICS Dr: Wael Hamdy Mansy Department of Pharmacology King Saud University.
Clinical Pharmacokinetics Fundamental hypothesis: a relationship exists between the pharmacological or toxic response to a drug and the accessible concentration.
1. Fate of drugs in the body 1.1 absorption 1.2 distribution - volume of distribution 1.3 elimination - clearance 2. The half-life and its uses 3. Repeated.
Continuous intravenous infusion (one-compartment model)
PHARMACOKINETICS Definition: quantitative study of drug absorption, distribution, metabolism, and excretion (ADME), and their mathematical relationship.
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
INTRODUCTION CLINICAL PHARMACOKINETICS
Principles of pharmacokinetics Prof. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague Cycle II, Subject: General.
Nonlinear Pharmacokinetics
INTRODUCTION Lecture 2.
Principles of Drug Action
The General Concepts of Pharmacokinetics and Pharmacodynamics
Pharmacokinetics 2 General Pharmacology M212
Learning objectives To know what data is available from pharmacokinetic studies in man and how to handle it To know how to calculate the basic pharmacokinetic.
METABOLISME DEPARTMENT OF PHARMACOLOGY AND THERAPEUTIC UNIVERSITAS SUMATERA UTARA dr. Yunita Sari Pane.
INTRODUCTION TO PHARMACOKINETICS M. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague, Charles University in Prague,
Source: Frank M. Balis Concentration and Effect vs. Time Conc./ Amount Effect [% of E MAX ] Time Central Compartment Peripheral Compartment Effect Compartment.
Allie punke Pharmacokinetics tutoring Fall 2016
Physiology for Engineers
Pharmacology Phone Number: (203)
Excretion of drugs.
Allie punke Pharmacokinetics tutoring Fall 2016
Pharmacokinetic Modeling (describing what happens)
Quantitative Pharmacokinetics
School of Pharmacy, University of Nizwa
Pharmacokinetics: Metabolism of Drugs
Pharmacokinetics and Factors of Individual Variation
1 Concentration-time curve
Biopharmaceutics Chapter-6
Introduction to Pharmacology
BIOAVAILABILITY.
Pharmacokinetics/Pharmacodynamics
Drug Metabolism.
Presentation transcript:

DISPOSITION OF DRUGS The disposition of chemicals entering the body (from C.D. Klaassen, Casarett and Doull’s Toxicology, 5th ed., New York: McGraw-Hill, 1996).

Bound Free Free Bound ABSORPTION Free Drug EXCRETION Bound Drug LOCUS OF ACTION “RECEPTORS” TISSUE RESERVOIRS Bound Free Free Bound ABSORPTION Free Drug EXCRETION SYSTEMIC CIRCULATION Bound Drug BIOTRANSFORMATION

Plasma concentration vs Plasma concentration vs. time profile of a single dose of a drug ingested orally Plasma Concentration

Bound Free Free Bound ABSORPTION Free Drug EXCRETION Bound Drug LOCUS OF ACTION “RECEPTORS” TISSUE RESERVOIRS Bound Free Free Bound ABSORPTION Free Drug EXCRETION SYSTEMIC CIRCULATION Bound Drug BIOTRANSFORMATION

Bioavailability Definition: the fraction of the administered dose reaching the systemic circulation for i.v.: 100% for non i.v.: ranges from 0 to 100% e.g. lidocaine bioavailability 35% due to destruction in gastric acid and liver metabolism First Pass Effect

Bioavailability Destroyed in gut Not absorbed Destroyed by gut wall by liver to systemic circulation Dose

PRINCIPLE For drugs taken by routes other than the i.v. route, the extent of absorption and the bioavailability must be understood in order to determine what dose will induce the desired therapeutic effect. It will also explain why the same dose may cause a therapeutic effect by one route but a toxic or no effect by another.

PRINCIPLE Drugs appear to distribute in the body as if it were a single compartment. The magnitude of the drug’s distribution is given by the apparent volume of distribution (Vd). Vd = Amount of drug in body ÷ Concentration in Plasma (Apparent) Volume of Distribution: Volume into which a drug appears to distribute with a concentration equal to its plasma concentration

Examples of apparent Vd’s for some drugs L/Kg L/70 kg Sulfisoxazole 0.16 11.2 Phenytoin 0.63 44.1 Phenobarbital 0.55 38.5 Diazepam 2.4 168 Digoxin 7 490

MAJOR MINOR

Elimination by the Kidney Excretion - major 1) glomerular filtration glomerular structure, size constraints, protein binding 2) tubular reabsorption/secretion - acidification/alkalinization, - active transport, competitive/saturable, organic acids/bases - protein binding Metabolism - minor

Elimination by the Liver Metabolism - major 1) Phase I and II reactions 2) Function: change a lipid soluble to more water soluble molecule to excrete in kidney 3) Possibility of active metabolites with same or different properties as parent molecule Biliary Secretion – active transport, 4 categories

The enterohepatic shunt Drug Liver Bile Bile formation duct Biotransformation; glucuronide produced Hydrolysis by beta glucuronidase gall bladder Portal circulation Gut

Influence of Variations in Relative Rates of Absorption and Elimination on Plasma Concentration of an Orally Administered Drug Ka/Ke=10 Ka/Ke=1 Ka/Ke=0.1 Plasma concentration Ka/Ke=0.01

Rate of elimination ∝ Amount Rate of elimination = K x Amount Zero order: constant rate of elimination irrespective of plasma concentration. First order: rate of elimination proportional to plasma concentration. Constant Fraction of drug eliminated per unit time. Rate of elimination ∝ Amount Rate of elimination = K x Amount

Zero Order Elimination Pharmacokinetics of Ethanol Ethanol is distributed in total body water. Mild intoxication at 1 mg/ml in plasma. How much should be ingested to reach it? Answer: 42 g or 56 ml of pure ethanol (VdxC) Or 120 ml of a strong alcoholic drink like whiskey Ethanol has a constant elimination rate = 10 ml/h To maintain mild intoxication, at what rate must ethanol be taken now? at 10 ml/h of pure ethanol, or 20 ml/h of drink. Rarely Done DRUNKENNESS Coma Death

First Order Elimination dA/dt ∝A DA/dt = – k•A DC/dt = – k•C Ct = C0 . e – Kel •t lnCt = lnC0 – Kel • t logCt = logC0 – Kel •t 2.3 Plasma concentration y = b – a.x

First Order Elimination 10000 First Order Elimination 1000 Plasma Concentration 100 10 1 1 2 3 4 5 6 Time logCt = logC0 - Kel . t 2.303

Plasma Concentration Profile after a Single I.V. Injection

Vd = Dose/C0 lnCt = lnCo – Kel.t When t = 0, C = C0, i.e., the concentration at time zero when distribution is complete and elimination has not started yet. Use this value and the dose to calculate Vd.

t1/2 = 0.693/Kel lnCt = lnC0 – Kel.t When Ct = ½ C0, then Kel.t = 0.693. This is the time for the plasma concentration to reach half the original, i.e., the half-life of elimination.

PRINCIPLE Elimination of drugs from the body usually follows first order kinetics with a characteristic half-life (t1/2) and fractional rate constant (Kel).

First Order Elimination Clearance: volume of plasma cleared of drug per unit time. Clearance = Rate of elimination ÷ plasma conc. Half-life of elimination: time for plasma conc. to decrease by half. Useful in estimating: - time to reach steady state concentration. - time for plasma concentration to fall after dosing is stopped.

Total Body Clearance = CLliver + CLkidney + CLlungs + CLx BLOOD OUT CA CV IN BLOOD Blood Flow = Q ELIMINATED Rate of Elimination = QCA – QCV = Q(CA-CV) SIMILARLY FOR OTHER ORGANS Liver Clearance = Q(CA-CV)/CA = Q x EF • Renal Clearance = Ux•V/Px Total Body Clearance = CLliver + CLkidney + CLlungs + CLx

Rate of elimination = Kel x Amount in body Rate of elimination = CL x Plasma Concentration Therefore, Kel x Amount = CL x Concentration Kel = CL/Vd 0.693/t1/2 = CL/Vd t1/2 = 0.693 x Vd/CL

PRINCIPLE The half-life of elimination of a drug (and its residence in the body) depends on its clearance and its volume of distribution t1/2 is proportional to Vd t1/2 is inversely proportional to CL t1/2 = 0.693 x Vd/CL

Multiple dosing On continuous steady administration of a drug, plasma concentration will rise fast at first then more slowly and reach a plateau, where: rate of administration = rate of elimination ie. steady state is reached. Therefore, at steady state: Dose (Rate of Administration) = clearance x plasma conc. Or If you aim at a target plasma level and you know the clearance, you can calculate the dose required.

Constant Rate of Administration (i.v.)

Repeated doses –Maintenance dose Single dose – Loading dose Therapeutic level Plasma Concentration Repeated doses –Maintenance dose Time

The time to reach steady state is ~4 t1/2’s Concentration due to repeated doses Concentration due to a single dose

Pharmacokinetic parameters Get equation of regression line; from it get Kel, C0 , and AUC Volume of distribution Vd = DOSE / C0 Plasma clearance Cl = Kel .Vd plasma half-life t1/2 = 0.693 / Kel Bioavailability (AUC)x / (AUC)iv

Dose = CL x AUC and Dose x F = CL x AUC dC/dt = CL x C dC = CL x C x dt But C x dt = small area under the curve. For total amount eliminated (which is the total given, or the dose, if i.v.), add all the small areas = AUC. Dose = CL x AUC and Dose x F = CL x AUC

Bioavailability (AUC)o (AUC)iv i.v. route Plasma concentration = i.v. route oral route Plasma concentration Time (hours)

Variability in Pharmacokinetics 60 50 40 Concentration (mg/L) Plasma Drug 30 20 10 5 10 15 Daily Dose (mg/kg)

PRINCIPLE The absorption, distribution and elimination of a drug are qualitatively similar in all individuals. However, for several reasons, the quantitative aspects may differ considerably. Each person must be considered individually and doses adjusted accordingly.